How to implement digital medicine in the futureYoon Sup Choi
by Yoon Sup Choi, PhD
yoonsup.choi@gmail.com
Professor, SAHIST, Sungkyunkwan University
Director, Digital Healthcare Institute
Managing Partner, Digital Healthcare Partners
How to implement digital medicine in the futureYoon Sup Choi
by Yoon Sup Choi, PhD
yoonsup.choi@gmail.com
Professor, SAHIST, Sungkyunkwan University
Director, Digital Healthcare Institute
Managing Partner, Digital Healthcare Partners
Wearables in Clinical Trials: Opportunities and ChallengesValencell, Inc
Wearables are showing the potential to significantly impact the data available for clinical trials and medical researchers in numerous ways. While the quality and efficacy of these devices varies widely, the sensor technologies in these devices has evolved to meet the needs of many clinical research endeavors. Wearables also enable longitudinal biometric data sets that can provide unique insights into the long-term, real-world impact of pharmacotherapies and treatment protocols. There are also many challenges in using wearables in trials, including access to the raw data from wearables, validation of the data from wearable devices, processing and analysis of massive amounts of wearable data, and data security.
This webinar is an interactive discussion on the state of wearables in clinical trials and medical research, where the opportunities are and the challenges to be overcome.
mHealth Israel_Hospitals and Healthcare Data_Carol Gomes_Stony Brook Universi...Levi Shapiro
Presentation by Carol Gomes, CEO / COO, Stony Brook University Hospital: Hospitals + Healthcare Data. Key Sections:
- Overview of Stony Brook Medicine Health System
- IT capital planning process
- Transition from Fee-for-Service
- Clinically Integrated Network
- Population Health Analytics Platform
- REGISTRIES – Benchmarking Quality
- Digital Transformation- Business & Clinical Capacity
- Transformation Projects: Analytics; Real-Time Health System Capabilities; Telehealth Services; Command Center Capabilities
- Command Center: Centralized Throughput Office (CTO)
- Command Throughput Office Dashboard
- Real-Time Dashboards
- Early Progress of Command Throughput Office (Boarders, Cases)
- Mobile STROKE Unit Program
- Telemedicine / TeleHealth
- Stony Brook University Hospital awarded $966,026
- Data Strategy in Decentralized Environment
- Call to Action for Startups
The Life-Changing Impact of AI in HealthcareKalin Hitrov
For IT Leaders in the healthcare and pharmaceutical industries looking to understand the impact of AI on their industries and how to overcome the ethical and efficiency challenges that come with its use.
apidays LIVE India - The digitisation of healthcare by Dr S.S. Lal, Global Fo...apidays
apidays LIVE India 2021 - Connecting 1.3 billion digital innovators
May 20, 2021
The digitisation of healthcare
Dr S.S. Lal, President of Global Foundation for Health and Hygiene
Blood pressure market research study - November 2020Valencell, Inc
In November 2020, Valencell conducted a research study on people with hypertension to understand the personal impact of managing the disease every day and the potential for digital health solutions to improve hypertension management.
Artificial intelligence-powered wearable solutions for senior care: A convers...Valencell, Inc
CarePredict, a Florida-based health tech startup, aims to improve seniors’ quality of life with machine learning-driven, actionable wearables insights for care staff and management to provide peace of mind for seniors and their loved ones. By identifying changes in the daily activities and behavior patterns of seniors, predictions can be made about declines in their health, thereby enabling early intervention and adopting a proactive and preventive approach to senior care.
In this webinar, CarePredict shares about their journey from initial concept through prototyping, use case development, business development, and addressing the crisis of a widening gap in the senior to caregiver ratio.
Best practices in using wearable biometric sensors to prove medical use casesValencell, Inc
The use of wearable devices in health and medical use cases is growing rapidly along with the number and capabilities of wearable devices. The sensor technology embedded in wearables today rivals the capabilities of regulatory-approved medical devices, and in many cases enables new and different use cases than we’ve seen possible before. This session will highlight the best practices we’ve seen emerging recently from real-world projects proving the efficacy of wearable devices in health and medical use cases in the areas of cardiovascular conditions, neurological disease, pain management, and other areas of interest. We’ll also explore the potential pitfalls to avoid and key things to consider when using wearables in proving out your medical use case.
Our Journey to Release a Patient-Centric AI App to Reduce Public Health CostsDatabricks
Health costs are exploding year by year. Thanks to Artificial Intelligence it is possible to address patient needs in a cost-efficient manner.
In the case we will present, we will demonstrate how as part of a telemedicine service we implemented a solution allowing to reduce triage cost of patients by leveraging AI. The app we developed not only allowed to reduce cost but is significantly improving the patient experience.
Hypertension management will change more in the next 5 years than in the last...Valencell, Inc
Why will managing hypertension change more in the next 5 years than it has in the last 100?
There are several macro trends that are driving this change:
- Hypertension is a massive global health problem (over 1B people have high BP) and it is THE leading risk factor for the global burden of disease (its a comorbidity in every major chronic disease) - more of a risk factor than tobacco, obesity, poor diet, high blood glucose, etc. - according to the WHO.
- Sensor tech - there has been no meaningful innovation in BP sensors in over 100 years. The BP cuffs in use today are fundamentally the same as the first BP cuff that came to market in the early 1900's. That’s changing now with cuffless BP sensors that are being approved by regulatory bodies.
- Care delivery – healthcare "has left the building", moving out of the hospital, into the home and everyday life. This can be seen in the huge growth in remote patient monitoring, digital therapeutics, and digital health more broadly.
- Payer models – insurance coverage is moving from fee-for-service to value-based care that’s focused on prevention and monitoring. This is particularly important in hypertension management because high BP has no outward symptoms, making the frequency and ease of BP monitoring extremely important.
Presentation covers basics of Big Data & its potential uses in healthcare. Data is growing & moving faster day by day. Getting access to this valuable data & factoring it into clinical & advanced analytics is critical to improve care. So there must be analysis of big data to make effective decisions.
Webinar: Calibration-free blood pressure monitoring using biometric earbudsValencell, Inc
Valencell was scheduled to present the results of a clinical study on its groundbreaking blood pressure monitoring technology at the American College of Cardiology conference in March, but unfortunately that conference was cancelled. So we’ve decided to share that presentation and research here in a webinar format with an open Q&A session. You can find more information on Valencell's blood pressure technology here: https://valencell.com/bloodpressure/
Integrate RWE into clinical developmentIMSHealthRWES
With greater application of RWE throughout the pharmaceutical
lifecycle, learnings are emerging that offer guidance for
approaches to derive the maximum value. This article captures
the author’s experience at a leading international biotech, with
insights for smoothing RWE assimilation into clinical
development and realizing the benefits it brings.
Wearables in Clinical Trials: Opportunities and ChallengesValencell, Inc
Wearables are showing the potential to significantly impact the data available for clinical trials and medical researchers in numerous ways. While the quality and efficacy of these devices varies widely, the sensor technologies in these devices has evolved to meet the needs of many clinical research endeavors. Wearables also enable longitudinal biometric data sets that can provide unique insights into the long-term, real-world impact of pharmacotherapies and treatment protocols. There are also many challenges in using wearables in trials, including access to the raw data from wearables, validation of the data from wearable devices, processing and analysis of massive amounts of wearable data, and data security.
This webinar is an interactive discussion on the state of wearables in clinical trials and medical research, where the opportunities are and the challenges to be overcome.
mHealth Israel_Hospitals and Healthcare Data_Carol Gomes_Stony Brook Universi...Levi Shapiro
Presentation by Carol Gomes, CEO / COO, Stony Brook University Hospital: Hospitals + Healthcare Data. Key Sections:
- Overview of Stony Brook Medicine Health System
- IT capital planning process
- Transition from Fee-for-Service
- Clinically Integrated Network
- Population Health Analytics Platform
- REGISTRIES – Benchmarking Quality
- Digital Transformation- Business & Clinical Capacity
- Transformation Projects: Analytics; Real-Time Health System Capabilities; Telehealth Services; Command Center Capabilities
- Command Center: Centralized Throughput Office (CTO)
- Command Throughput Office Dashboard
- Real-Time Dashboards
- Early Progress of Command Throughput Office (Boarders, Cases)
- Mobile STROKE Unit Program
- Telemedicine / TeleHealth
- Stony Brook University Hospital awarded $966,026
- Data Strategy in Decentralized Environment
- Call to Action for Startups
The Life-Changing Impact of AI in HealthcareKalin Hitrov
For IT Leaders in the healthcare and pharmaceutical industries looking to understand the impact of AI on their industries and how to overcome the ethical and efficiency challenges that come with its use.
apidays LIVE India - The digitisation of healthcare by Dr S.S. Lal, Global Fo...apidays
apidays LIVE India 2021 - Connecting 1.3 billion digital innovators
May 20, 2021
The digitisation of healthcare
Dr S.S. Lal, President of Global Foundation for Health and Hygiene
Blood pressure market research study - November 2020Valencell, Inc
In November 2020, Valencell conducted a research study on people with hypertension to understand the personal impact of managing the disease every day and the potential for digital health solutions to improve hypertension management.
Artificial intelligence-powered wearable solutions for senior care: A convers...Valencell, Inc
CarePredict, a Florida-based health tech startup, aims to improve seniors’ quality of life with machine learning-driven, actionable wearables insights for care staff and management to provide peace of mind for seniors and their loved ones. By identifying changes in the daily activities and behavior patterns of seniors, predictions can be made about declines in their health, thereby enabling early intervention and adopting a proactive and preventive approach to senior care.
In this webinar, CarePredict shares about their journey from initial concept through prototyping, use case development, business development, and addressing the crisis of a widening gap in the senior to caregiver ratio.
Best practices in using wearable biometric sensors to prove medical use casesValencell, Inc
The use of wearable devices in health and medical use cases is growing rapidly along with the number and capabilities of wearable devices. The sensor technology embedded in wearables today rivals the capabilities of regulatory-approved medical devices, and in many cases enables new and different use cases than we’ve seen possible before. This session will highlight the best practices we’ve seen emerging recently from real-world projects proving the efficacy of wearable devices in health and medical use cases in the areas of cardiovascular conditions, neurological disease, pain management, and other areas of interest. We’ll also explore the potential pitfalls to avoid and key things to consider when using wearables in proving out your medical use case.
Our Journey to Release a Patient-Centric AI App to Reduce Public Health CostsDatabricks
Health costs are exploding year by year. Thanks to Artificial Intelligence it is possible to address patient needs in a cost-efficient manner.
In the case we will present, we will demonstrate how as part of a telemedicine service we implemented a solution allowing to reduce triage cost of patients by leveraging AI. The app we developed not only allowed to reduce cost but is significantly improving the patient experience.
Hypertension management will change more in the next 5 years than in the last...Valencell, Inc
Why will managing hypertension change more in the next 5 years than it has in the last 100?
There are several macro trends that are driving this change:
- Hypertension is a massive global health problem (over 1B people have high BP) and it is THE leading risk factor for the global burden of disease (its a comorbidity in every major chronic disease) - more of a risk factor than tobacco, obesity, poor diet, high blood glucose, etc. - according to the WHO.
- Sensor tech - there has been no meaningful innovation in BP sensors in over 100 years. The BP cuffs in use today are fundamentally the same as the first BP cuff that came to market in the early 1900's. That’s changing now with cuffless BP sensors that are being approved by regulatory bodies.
- Care delivery – healthcare "has left the building", moving out of the hospital, into the home and everyday life. This can be seen in the huge growth in remote patient monitoring, digital therapeutics, and digital health more broadly.
- Payer models – insurance coverage is moving from fee-for-service to value-based care that’s focused on prevention and monitoring. This is particularly important in hypertension management because high BP has no outward symptoms, making the frequency and ease of BP monitoring extremely important.
Presentation covers basics of Big Data & its potential uses in healthcare. Data is growing & moving faster day by day. Getting access to this valuable data & factoring it into clinical & advanced analytics is critical to improve care. So there must be analysis of big data to make effective decisions.
Webinar: Calibration-free blood pressure monitoring using biometric earbudsValencell, Inc
Valencell was scheduled to present the results of a clinical study on its groundbreaking blood pressure monitoring technology at the American College of Cardiology conference in March, but unfortunately that conference was cancelled. So we’ve decided to share that presentation and research here in a webinar format with an open Q&A session. You can find more information on Valencell's blood pressure technology here: https://valencell.com/bloodpressure/
Integrate RWE into clinical developmentIMSHealthRWES
With greater application of RWE throughout the pharmaceutical
lifecycle, learnings are emerging that offer guidance for
approaches to derive the maximum value. This article captures
the author’s experience at a leading international biotech, with
insights for smoothing RWE assimilation into clinical
development and realizing the benefits it brings.
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...Andrew Aijian
We conducted interviews with precision medicine KOLs to create a map of the precision medicine stakeholder landscape and identify and understand the unmet needs and pain points within precision medicine, as well as areas and scenarios of potential disruption.
Here are the ways to describe What is Medical Technology and how it works? ; 1. What does it entail? 2. The following is a description of what constitutes a medical device according to the World Health Organization:
Strengthening Health Systems through the application of Wireless TechnologyOPS Colombia
Presentación realizada por el Dr. Trishan Panch, de Harvard School of Public Health, el 20 de Septiembre en OPS Colombia, en el espacio de intercambio sobre e-health.
El Dr. Panch, participa, con el auspicio de esta Representación, como conferencista en el IV Congreso Colombiano de Bioingeniería e Ingeniería Biomédica que se realizará en Barranquilla del 21 al 24 de septiembre del 2011.
The 10 best medical & clinical laboratories to watch for 2019insightscare
Insights Care has curated a list of “The 10 Best Medical & Clinical Laboratories to watch for 2019” we are showcasing the companies that have paved their way innovation through uniqueness.
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
Technology is slowly but surely penetrating the healthcare industry in general and the clinical trials sector in particular. New and advanced solutions offer a variety of possibilities aimed to both improving existing processes and creating new and more efficient ones. And on top of all stands the desire to make clinical trials more patient centric.
In all of this, even though some of the technologies have yet to mature enough to meet the high quality standards necessary, it is important to know them and begin imagining the promise they hold for clinical trials.
Most reliable diagnostic and pathology center to watch..Merry D'souza
This edition of Most Reliable Diagnostic and Pathology Centres to Watch places the spotlight on healthcare service providers that are leveraging such revolutionary technologies to deliver the best to those seeking their services.
We welcomed Dr. Andrew Feifer for a presentation about Ned, an app designed specifically for prostate cancer patients, as well as a discussion about the incorporation of data driven smart technology in the survivorship of cancer patients.
The webinar was followed by an interactive question & answer session.
Ned was conceptualized and co-founded by our webinar presenter: Dr. Andrew Feifer, a Urologic Surgical Oncologist at Trillium Health Centre in Toronto. Dr. Feifer evisioned a tool that would empower prostate cancer survivors by putting their health into their own hands and giving them more options to manage their own care.
10 most trusted clinical laboratories in 2021Merry D'souza
To honor the diligent services of clinical laboratories, we came up with this edition of Insights Care - 10 Most Trusted Clinical Laboratories in 2021.
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
Remote sensing and monitoring are changing the mining industry for the better. These are providing innovative solutions to long-standing challenges. Those related to exploration, extraction, and overall environmental management by mining technology companies Odisha. These technologies make use of satellite imaging, aerial photography and sensors to collect data that might be inaccessible or from hazardous locations. With the use of this technology, mining operations are becoming increasingly efficient. Let us gain more insight into the key aspects associated with remote sensing and monitoring when it comes to mining.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
India Orthopedic Devices Market: Unlocking Growth Secrets, Trends and Develop...Kumar Satyam
According to TechSci Research report, “India Orthopedic Devices Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the India Orthopedic Devices Market stood at USD 1,280.54 Million in 2024 and is anticipated to grow with a CAGR of 7.84% in the forecast period, 2026-2030F. The India Orthopedic Devices Market is being driven by several factors. The most prominent ones include an increase in the elderly population, who are more prone to orthopedic conditions such as osteoporosis and arthritis. Moreover, the rise in sports injuries and road accidents are also contributing to the demand for orthopedic devices. Advances in technology and the introduction of innovative implants and prosthetics have further propelled the market growth. Additionally, government initiatives aimed at improving healthcare infrastructure and the increasing prevalence of lifestyle diseases have led to an upward trend in orthopedic surgeries, thereby fueling the market demand for these devices.
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
10. Digital Healthcare Industry Landscape
Data Measurement Data Integration Data Interpretation Treatment
Smartphone Gaget/Apps
DNA
Artificial Intelligence
Telemedicine
2nd Opinion
Device
On Demand (O2O)
Wearables / IoT
3D Printer
Counseling
(ver. 2)
Digital Healthcare Institute
Diretor, Yoon Sup Choi, Ph.D.
yoonsup.choi@gmail.com
EMR/EHR
Data Platform
Accelerator/early-VC
11. Digital Healthcare Industry Landscape
Data Measurement Data Integration Data Interpretation Treatment
Smartphone Gaget/Apps
DNA
Artificial Intelligence
Telemedicine
Device
On Demand (O2O)
Wearables / IoT
3D Printer
Counseling
(ver. 2)
Digital Healthcare Institute
Diretor, Yoon Sup Choi, Ph.D.
yoonsup.choi@gmail.com
EMR/EHR
Data Platform
Accelerator/early-VC
14. 아무도 원하지 않는 제품을 만들고 있는 것은 아닌가?
• 진짜 니즈가 무엇인지 파악하라
• 고객들이 원한다고 말하는 것 (X)
• 고객들이 원한다고 당신이 생각하는 것 (X)
• 실제로 진짜 고객들이 원하는 것 (O)
• 무엇이 가능한지 모르기 때문에, 고객은 스스로 무엇을 원하는지 모를 것이다.
29. 의료적 관점에서도 동의할 수 있는 해결책인가
• 의료 전문가 (의사)의 조언이 필요하다.
• 과학적/의학적 설득력이 없는 (a.k.a. 사이비) 서비스/제품은 곤란하다.
• 의료 현실에 맞지 않는 서비스는 외면 당하거나, 극심한 반대에 부딪힌다.
• 초기 팀원 중에 의사가 꼭 있을 필요는 없지만, 조언을 얻을 수 있는 분은 필요하다.
• 의사들 사이에서도 성향 차이 / 의견 차이가 존재한다.
36. 한국 의료 시스템의 특수성을 이해하라
• 한국 의료 체계는 미국과는 크게 다르다.
• 국내 의료 시스템의 특성을 명확히 파악할 필요가 있다.
• 의료 접근성, 의료 보험 체계, 의료 수가 등등
• 미국에서 통했던 것이, 한국에서는 통하지 않거나 / 아예 불법일 수 있다.
• 그렇다고 꼭 국내 시장에 국한될 필요는 없다.
44. 헬스케어넓은 의미의 건강 관리에는 해당되지만,
디지털 기술이 적용되지 않고, 전문 의료 영역도 아닌 것
예) 운동, 영양, 수면
디지털 헬스케어
건강 관리 중에 디지털 기술이 사용되는 것
예) 사물인터넷, 인공지능, 3D 프린터
모바일 헬스케어
디지털 헬스케어 중
모바일 기술이 사용되는 것
예) 스마트폰, 사물인터넷, SNS
개인 유전정보분석
예) 암유전체, 질병위험도,
보인자, 약물 민감도
예) 웰니스, 조상 분석
헬스케어 관련 분야 구성도(ver 0.3)
의료
질병 예방, 치료, 처방, 관리
등 전문 의료 영역
원격의료
원격진료
45. 헬스케어는 규제 산업이다
• 규제는 본질적으로 기술의 발전을 뒤따를 수 밖에 없다.
• 국내 규제 상황은 별로 좋지 않다.
• 합리성, 일관성, 불확실성
• 싫든 좋든, 규제를 개척하는 것도 역할의 하나이다.
• 하지만 식약처도 열심히 일하고 있다.
• 초기에 식약처 등 관련 기관을 컨택하는 것도 필요하다.
47. • 헬스케어/의료 서비스는 근거가 필수적이다.
• 하지만 그렇지 못한 것이 현실
applications, from photometric diagnostics to
medical-grade imaging (16).Taking advantage of
these properties, newly developed devices permit
the automated determination of refractive error
merely by having an individual look through a
lens attached to a smartphone (17). Another
transportable imaging capability involves the
enabling of remote diagnosis through the use of
a smartphone case with an attached otoscope
(for detecting an ear infection) (18), multimodal
colposcope for cervical cancer identification (19),
or optical screening tool for potentially cancerous
oral lesions (20). Dermatologic diagnostics may be
especially well suited for exploiting the myriad
smartphone capabilities for teledermatology (21).
The technologies highlighted above can improve
care simply through their ability to markedly in-
crease the accessibility and convenience of care
by bringing clinic- and hospital-quality moni-
toring and diagnostics to the point of need. How-
ever, their greatest potential might be in allowing
for the complete redefining of “normal” physio-
logical responses and in enhancing our under-
standing of the natural histories of poorly defined
chronic conditions. Continuous beat-to-beat moni-
toring of blood pressure throughout daily activities
will help to refine the catchall diagnosis of “essential hypertension” as
multiple distinct phenotypes. Similarly, understanding individual varia-
views conclude that high-quality evidence is lacking for the use of
mHealth to effect behavioral changes or to manage chronic diseases,
1000
Funding ($) in millions
Publications
Funding($inmillions)
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
800
600
400
200
0
10,000
8000
6000
4000
2000
0
WoSpublications(number)
Fig. 2. mHealth taking center stage. Measures are funding and number of related publications.
Shown are the annual total funding for patient-facing mHealth companies and the annual num-
ber of related publications [identified with Web of Science (WoS) using search terms “telemedi-
cine” and “mhealth*” and “digital health” and “digital medicine”]. Funding data provided by
B. Dolan and A. Pai of MobiHealthNews.
R E V I E W
onApril27,2015emag.org
근거를 만들어야 한다.
48. 근거를 만들어야 한다.
• 의료 기관과의 협업이 필요할 가능성이 높다.
• 하지만 의료 기관과 일하기 쉽지 않다.
• Right person, Right hospital, Right department, Right time…
• 의사의 관심과 스타트업의 관심사가 다르다.
• 의사와 스타트업의 공통점: 리소스가 턱없이 부족하다.
• 가장 좋은 근거는 역시 임상 연구 결과
• 연구 조건은 case by case.
• Randomised, Double-blinded, controlled trial.
• 충분한 N 수, 충분한 기간
52. The Journal of Clinical Investigation C L I N I C A L M E D I C I N E
Introduction
Clinical laboratory testing plays a critical role in health care and
evidence-based medicine (1). Lab tests provide essential data
that support clinical decisions to screen, diagnose, and treat
health conditions (2). Most individuals encounter clinical testing
through their health care provider during a routine health assess-
ment or as a patient in a health care facility. However, individu-
als are increasingly playing more active roles in managing their
health, and some now seek direct access to laboratory testing for
self-guided assessment or monitoring (3–5).
IntheUSA,allclinicallaboratorytestingconductedonhumans
is regulated by Centers for Medicare & Medicaid Services (CMS)
based on guidelines outlined in Clinical Laboratory Improvement
Amendments (CLIA) (6). To ensure analytical quality of labora-
tory methods, certified laboratories are required to participate in
periodic proficiency testing using a homogeneous batch of sam-
ples that are distributed to each laboratory from a CMS-approved
proficiency testing program. These programs assess the total
allowable error (TEa) that combines method bias and total impre-
cision for each analyte. Acceptability criteria are determined by
CLIA and/or the appropriate accrediting agency (7).
Direct-to-consumer service models now provide means for
individuals to obtain laboratory testing outside traditional health
care settings (4, 5). One company implementing this new model is
Theranos, which offers a blood testing service that uses capillary
tube collection and promises several advantages over traditional
venipuncture: lower collection volumes (typically ≤150 μl versus
≥1.5 ml), convenience, and reduced cost — on average about 5-fold
less than the 2 largest testing laboratories in the USA (Quest and
LabCorp) (8). However, availability of these services varies by
state, where access to offerings may be more or less restrictive
BACKGROUND. Clinical laboratory tests are now being prescribed and made directly available to consumers through retail
outlets in the USA. Concerns with these test have been raised regarding the uncertainty of testing methods used in these
venues and a lack of open, scientific validation of the technical accuracy and clinical equivalency of results obtained through
these services.
METHODS. We conducted a cohort study of 60 healthy adults to compare the uncertainty and accuracy in 22 common clinical
lab tests between one company offering blood tests obtained from finger prick (Theranos) and 2 major clinical testing services
that require standard venipuncture draws (Quest and LabCorp). Samples were collected in Phoenix, Arizona, at an ambulatory
clinic and at retail outlets with point-of-care services.
RESULTS. Theranos flagged tests outside their normal range 1.6× more often than other testing services (P < 0.0001). Of the
22 lab measurements evaluated, 15 (68%) showed significant interservice variability (P < 0.002). We found nonequivalent
lipid panel test results between Theranos and other clinical services. Variability in testing services, sample collection times,
and subjects markedly influenced lab results.
CONCLUSION. While laboratory practice standards exist to control this variability, the disparities between testing services
we observed could potentially alter clinical interpretation and health care utilization. Greater transparency and evaluation of
testing technologies would increase their utility in personalized health management.
FUNDING. This work was supported by the Icahn Institute for Genomics and Multiscale Biology, a gift from the Harris Family
Charitable Foundation (to J.T. Dudley), and grants from the NIH (R01 DK098242 and U54 CA189201, to J.T. Dudley, and R01
AG046170 and U01 AI111598, to E.E. Schadt).
Evaluation of direct-to-consumer low-volume lab tests
in healthy adults
Brian A. Kidd,1,2,3
Gabriel Hoffman,1,2
Noah Zimmerman,3
Li Li,1,2,3
Joseph W. Morgan,3
Patricia K. Glowe,1,2,3
Gregory J. Botwin,3
Samir Parekh,4
Nikolina Babic,5
Matthew W. Doust,6
Gregory B. Stock,1,2,3
Eric E. Schadt,1,2
and Joel T. Dudley1,2,3
1
Department of Genetics and Genomic Sciences, 2
Icahn Institute for Genomics and Multiscale Biology, 3
Harris Center for Precision Wellness, 4
Department of Hematology and Medical Oncology, and
5
Department of Pathology, Icahn School of Medicine at Mount Sinai, NewYork, NewYork, USA. 6
Hope Research Institute (HRI), Phoenix, Arizona, USA.
Conflict of interest: J.T. Dudley owns equity in NuMedii Inc. and has received consulting
fees or honoraria from Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca, and
LAM Therapeutics.
Role of funding source: Study funding provided by the Icahn Institute for Genomics
and Multiscale Biology and the Harris Center for Precision Wellness at the Icahn
School of Medicine at Mount Sinai. Salaries of B.A. Kidd, J.T. Dudley, and E.E. Schadt
Downloaded from http://www.jci.org on March 28, 2016. http://dx.doi.org/10.1172/JCI86318
•Mt Sinai 에서 내어놓은 Theranos 의 정확도에 대한 논문
•2015년 7월 경에 60명의 건강한 환자들을 대상으로 5일 간에 걸쳐서
•22가지의 검사 항목을 테라노스와 또 다른 두 군데의 검사 기관에 맡겨서 결과를 비교
•결론적으로 Theranos의 결과가 많이 부정확
•콜레스테롤 등의 경우는 의사의 진단이 바뀔 정도로 크게 부정확
•전반적인 테스트들 결과 정상 범위가 아니라고 판단하는 경우가 테라노스가 1.6배 많음
•22개의 검사 항목 중에서 15개에서 유의미하게 결과의 차이가 있었습니다.
•논문에서는 알 수 없는 또 다른 문제
•Theranos가 자체적으로 개발했다고 '주장' 했던 에디슨 기기를 정말로 썼느냐...하는 것
•WSJ 에 나온 과거 직원의 증언에 따르면, 이미 2015년 7월경이라면,
•에디슨 기기를 쓰지 않고 지멘스 등 기존 다른 기기에 혈액을 희석해서 쓰고 있을 때
•역시나(?) 이번에도 테라노스는 conflict-of-interest 가 있는 잘못된 논문이라는 반응
54. Effects of virtual reality-based rehabilitation on distal
upper extremity function and health-related quality of life:
a single-blinded, randomized controlled trial
ments at T2 and 23 completed the follow-up assessments
at T3. During the study, 5 and 8 participants from the SG
and CON groups, respectively, did not complete the inter-
vention programs. The sample sizes at the assessment time
points are presented in Fig. 2. There were no serious ad-
verse events, and only 1 participant from the CON group
dropped out owing to dizziness, which was unrelated to
the intervention. Thus, most of the study withdrawals were
related to uncooperativeness, and the number was higher
than that hypothesized in the study design. At baseline,
dist: F = 4.64, df = 1.38, P = 0.024).
Secondary outcomes
Jebsen–Taylor hand function test
The JTT scores of the SG and CON groups are presented
in Table 2. There were no significant differences in the
JTT-total, JTT-gross, and JTT-fine scores between the 2
groups at T0. The post-hoc test found that there were sig-
nificant improvements in the JTT-total, JTT-gross, and
JTT-fine scores in the SG group during the intervention
Fig. 2 Flowchart of the participants through the study. Abbreviations: SG, Smart Glove; CON, conventional intervention
Shin et al. Journal of NeuroEngineering and Rehabilitation (2016) 13:17
Shin et al. Journal of NeuroEngineering and Rehabilitation (2016) 13:17
55. Effects of virtual reality-based rehabilitation on distal
upper extremity function and health-related quality of life:
a single-blinded, randomized controlled trial
composite SIS score (F = 5.76, df = 1.0, P = 0.021) and
the overall SIS score (F = 6.408, df = 1.0, P = 0.015).
Moreover, among individual domain scores, the Time ×
standard OT than using amount-matched conventional re-
habilitation, without any adverse events, in stroke survivors.
Additionally, this study noted improvements in the SIS-
Fig. 3 Mean and standard errors for the FM scores in the SG and
CON groups. Abbreviations: FM, Fugl–Meyer assessment, SG, Smart
Glove; CON, conventional intervention
Fig. 4 Mean and standard errors for the JTT scores in the SG and
CON groups. Abbreviations: JTT, Jebsen–Taylor hand function test;
SG, Smart Glove; CON, conventional intervention
Shin et al. Journal of NeuroEngineering and Rehabilitation (2016) 13:17 Page 7 of 10
composite SIS score (F = 5.76, df = 1.0, P = 0.021) and
the overall SIS score (F = 6.408, df = 1.0, P = 0.015).
standard OT than using amount-matched conventional re-
habilitation, without any adverse events, in stroke survivors.
Fig. 3 Mean and standard errors for the FM scores in the SG and
CON groups. Abbreviations: FM, Fugl–Meyer assessment, SG, Smart
Glove; CON, conventional intervention
Fig. 4 Mean and standard errors for the JTT scores in the SG and
CON groups. Abbreviations: JTT, Jebsen–Taylor hand function test;
SG, Smart Glove; CON, conventional intervention
Shin et al. Journal of NeuroEngineering and Rehabilitation (2016) 13:17 Page 7 of 10
Shin et al. Journal of NeuroEngineering and Rehabilitation (2016) 13:17
57. Weight loss efficacy of a novel mobile Diabetes Prevention
Program delivery platform with human coaching
Weight loss efficacy of a novel mobile
Diabetes Prevention Program delivery
platform with human coaching
Andreas Michaelides, Christine Raby, Meghan Wood, Kit Farr, Tatiana Toro-Ramos
To cite: Michaelides A,
Raby C, Wood M, et al.
Weight loss efficacy of a
novel mobile Diabetes
Prevention Program delivery
platform with human
coaching. BMJ Open
Diabetes Research and Care
2016;4:e000264.
doi:10.1136/bmjdrc-2016-
000264
Received 4 May 2016
Revised 19 July 2016
Accepted 11 August 2016
ABSTRACT
Objective: To evaluate the weight loss efficacy of a
novel mobile platform delivering the Diabetes
Prevention Program.
Research Design and Methods: 43 overweight or
obese adult participants with a diagnosis of
prediabetes signed-up to receive a 24-week virtual
Diabetes Prevention Program with human coaching,
through a mobile platform. Weight loss and
engagement were the main outcomes, evaluated by
repeated measures analysis of variance, backward
regression, and mediation regression.
Results: Weight loss at 16 and 24 weeks was
significant, with 56% of starters and 64% of
completers losing over 5% body weight. Mean weight
loss at 24 weeks was 6.58% in starters and 7.5% in
completers. Participants were highly engaged, with
84% of the sample completing 9 lessons or more.
In-app actions related to self-monitoring significantly
predicted weight loss.
Conclusions: Our findings support the effectiveness
of a uniquely mobile prediabetes intervention,
producing weight loss comparable to studies with high
engagement, with potential for scalable population
health management.
INTRODUCTION
Lifestyle interventions,1
including the
National Diabetes Prevention Program
(NDPP) have proven effective in preventing
type 2 diabetes.2 3
Online delivery of an
adapted NDPP has resulted in high levels of
engagement, weight loss, and improvements
in glycated hemoglobin (HbA1c).4 5
Prechronic and chronic care efforts delivered
6
convenient, and accessible method to deliver
the NDPP.
The weight loss efficacy of a completely
mobile delivery of a structured NDPP has not
been tested. The main aim of this pilot study
was to evaluate the weight loss efficacy of
Noom’s smartphone-based NDPP-based cur-
ricula with human coaching in a group of
overweight and obese hyperglycemic adults
receiving 16 weeks of core, plus postcore cur-
riculum. In this study, it was hypothesized
that the mobile DPP could produce trans-
formative weight loss over time.
RESEARCH DESIGN AND METHODS
A large Northeast-based insurance company
offered its employees free access to Noom
Key messages
▪ To the best of our knowledge, this study is the
first fully mobile translation of the Diabetes
Prevention Program.
▪ A National Diabetes Prevention Program (NDPP)
intervention delivered entirely through a smart-
phone platform showed high engagement and
6-month transformative weight loss, comparable
to the original NDPP and comparable to trad-
itional in-person programmes.
▪ This pilot shows that a novel mobile NDPP inter-
vention has the potential for scalability, and can
address the major barriers facing the widespread
translation of the NDPP into the community
setting, such as a high fixed overhead, fixed
locations, and lower levels of engagement and
weight loss.
Open Access Research
group.bmj.comon September 23, 2016 - Published byhttp://drc.bmj.com/Downloaded from
62. 의료/헬스케어 전문가
의료기관과의 협력
Exit 경험이 있는 기업가
자금 조달 전문가
제조 기술 전문가
해외 시장 진출 지원
0 10 20 30 40
헬스케어 스타트업이 엑셀러레이터로부터 가장 지원받기를 원하는 요소는?
(2016.3 자체 조사)
63.
64.
65. DHP는 최고의 의료 전문가들이 초기 헬스케어 스타트업에
의학 자문, 의료 기관 연계, 임상 검증, 투자 유치 등을 지원합니다.
최윤섭 대표파트너 정지훈 파트너 김치원 파트너
• 성균관대학교 디지털헬스학과 교수
• 최윤섭 디지털 헬스케어 연구소 소장
• VUNO, Zikto, 녹십자홀딩스 등 자문
• 저서: ‘헬스케어 이노베이션’
• 전) 서울대학교 의과대학 암연구소 교수
• 전) 서울대학교병원 의생명연구원 교수
• 포항공대 전산생물학 이학박사
• 포항공대 컴퓨터공학/생명과학 학사
• 경희사이버대학 미디어모바일 전공 교수
• 빅뱅엔젤스 파트너
• Lunit, 매직에코, 휴레이포지티브 등 자문
• 저서: ‘제 4의 불', ‘거의 모든 IT의 역사’ 등
• 전) 명지병원 IT융합연구소장
• 한양대학교 의과대학 졸업
• 서울대학교 보건정책관리학 석사
• USC 의공학박사
• 내과전문의, 서울와이즈요양병원 원장
• 성균관대학교 디지털 헬스학과 교수
• Noom, Zikto, Future Play 등 자문
• 저서: ‘의료, 미래를 만나다’
• 전) 맥킨지 서울사무소 경영컨설턴트
• 전) 삼성서울병원 의료관리학과 교수
• 서울대학교 의과대학 졸업
• 연세대학교 보건대학원 석사